Free Trial

Cardiol Therapeutics (CRDL) Competitors

Cardiol Therapeutics logo
C$1.97 -0.10 (-4.83%)
As of 04:00 PM Eastern

CRDL vs. PYR, NVO, DNA, TLRY, VBV, CUS, AIM, FRX, ITH, and IPA

Should you be buying Cardiol Therapeutics stock or one of its competitors? The main competitors of Cardiol Therapeutics include PyroGenesis Canada Inc. (PYR.V) (PYR), Novo Resources Corp. (NVO.V) (NVO), Dalradian Resources (DNA), Tilray Brands (TLRY), VBI Vaccines (VBV), Chemtrade Electrochem Inc, (CUS), Aimia (AIM), Fennec Pharmaceuticals (FRX), International Tower Hill Mines (ITH), and ImmunoPrecise Antibodies (IPA). These companies are all part of the "pharmaceutical products" industry.

Cardiol Therapeutics vs. Its Competitors

Cardiol Therapeutics (TSE:CRDL) and PyroGenesis Canada Inc. (PYR.V) (CVE:PYR) are both small-cap pharmaceutical products companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, media sentiment, institutional ownership and earnings.

11.4% of Cardiol Therapeutics shares are held by institutional investors. 4.6% of Cardiol Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

PyroGenesis Canada Inc. (PYR.V)'s return on equity of 0.00% beat Cardiol Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Cardiol TherapeuticsN/A -195.07% -54.15%
PyroGenesis Canada Inc. (PYR.V) N/A N/A N/A

PyroGenesis Canada Inc. (PYR.V) has higher revenue and earnings than Cardiol Therapeutics. PyroGenesis Canada Inc. (PYR.V) is trading at a lower price-to-earnings ratio than Cardiol Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardiol TherapeuticsN/AN/A-C$42.93M-C$0.51-3.87
PyroGenesis Canada Inc. (PYR.V)C$6.01M100.97-C$3.94M-C$0.03-154.00

In the previous week, Cardiol Therapeutics and Cardiol Therapeutics both had 1 articles in the media. Cardiol Therapeutics' average media sentiment score of 0.00 equaled PyroGenesis Canada Inc. (PYR.V)'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cardiol Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
PyroGenesis Canada Inc. (PYR.V)
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

PyroGenesis Canada Inc. (PYR.V) beats Cardiol Therapeutics on 5 of the 8 factors compared between the two stocks.

Get Cardiol Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRDL vs. The Competition

MetricCardiol TherapeuticsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$163.47MC$2.14BC$5.45BC$6.19B
Dividend YieldN/A2.92%5.22%6.72%
P/E Ratio-3.874.1527.2456.61
Price / SalesN/A563.67426.371,138.71
Price / Cash0.9810.3526.2183.29
Price / Book13.1911.477.924.69
Net Income-C$42.93MC$21.15BC$3.17BC$301.20M
7 Day Performance6.49%1.60%4.40%1.65%
1 Month Performance2.60%6.45%2.64%4.19%
1 Year Performance-27.04%2.38%35.04%27.78%

Cardiol Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRDL
Cardiol Therapeutics
N/AC$1.97
-4.8%
N/A-23.3%C$163.47MN/A-3.8720
PYR
PyroGenesis Canada Inc. (PYR.V)
N/AC$3.85
+11.0%
N/A+0.0%C$606.96MC$6.01M-154.0090News Coverage
Gap Up
NVO
Novo Resources Corp. (NVO.V)
N/AC$2.38
-0.4%
N/A+0.0%C$548.24MN/A-21.2554,400
DNA
Dalradian Resources
N/AN/AN/AN/AC$519.02MN/A-56.15640
TLRY
Tilray Brands
N/AC$0.53
+6.0%
N/A-71.4%C$341.52MC$610.34M-1.282,650Gap Up
VBV
VBI Vaccines
N/AN/AN/AN/AC$308.86MC$3.36M-4.9722
CUS
Chemtrade Electrochem Inc,
N/AN/AN/AN/AC$306.50MN/A0.0060
AIM
Aimia
2.4749 of 5 stars
C$2.82
-0.7%
C$4.00
+41.8%
+9.9%C$271.22MC$464.71M-3.4720Positive News
FRX
Fennec Pharmaceuticals
N/AC$11.56
+7.3%
N/A+52.6%C$222.93MC$34.86M-195.8210Insider Trade
Gap Up
High Trading Volume
ITH
International Tower Hill Mines
N/AC$1.22
+5.2%
N/A+73.9%C$171.28MN/A-50.97220Gap Up
IPA
ImmunoPrecise Antibodies
N/AC$6.50
+0.8%
N/A+0.0%C$162.08MC$19.47M-7.3080News Coverage
Gap Down

Related Companies and Tools


This page (TSE:CRDL) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners